PP
OPTR

Paloma Partners’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Paloma Partners’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-250,000
Closed -$3.15M – 1359
2013
Q3 		$3.15M Buy
250,000
+200,000
+400% +$2.65M 0.12% 138
2013
Q2 		$724K Buy
+50,000
New +$728K 0.04% 352

Paloma Partners's OPTR Position: Q4 2013 in Review

Paloma Partners sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 250,000 shares — an estimated $3.15M sold.

Paloma Partners first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $3.15M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Paloma Partners reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Paloma Partners sold 250,000 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $3.15M.
  • Paloma Partners first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Paloma Partners's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $3.15M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Paloma Partners's 13F filing for Q4 2013, filed 14 Feb 2014.